Pharmafile Logo
Pharmafocus logo
Advanced Search
GSK sign

GSK submits new Promacta licence

March 3, 2014
Sales and Marketing GSK, NICE, Promacta, Revolade, blood, eltrombopag

GlaxoSmithKline is seeking a new licence for its blood disorder drug Promacta in patients with severe aplastic anaemia. Specifically, the …

News
neil_flash

dna Medical Communications hires MD

March 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dna Medical Communications, neil flash

Neil Flash has joined healthcare agency dna Medical Communications as the managing director for its UK team. Flash joined dna …

Appointment
Blood pressure image

Look beyond the screen

March 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, cliinical, data, screening, trials

It makes sense, doesn’t it? You have a drug that’s effective for a certain disease, but no patients. What do …

Feature
Hunt image

Insurance firms ‘will not be sold records’

March 3, 2014
Sales and Marketing GPs, HSCIC, Hunt, NHS, care data, care.data

The government is to pledge that insurance companies will not be sold patients’ health records via the care.data information sharing …

News
dh image

Government questions innovation uptake by doctors

February 28, 2014
Medical Communications, Sales and Marketing ABPI, Hunt, NHS, PPRS, UK, doctors

The government has launched a consultation which aims to establish whether doctors are being held back from using innovative treatments, …

News
Witty image

GSK’s Witty loses bonus over China scandal

February 28, 2014
Medical Communications, Sales and Marketing China, GSK, Witty, sales, sir andrew

GlaxoSmithKline’s chief executive Sir Andrew Witty received bonuses “lower than they otherwise might have been” last year due to the …

News

Packer Forbes Communications adds managing director

February 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Packer Forbes, joella webber

Comms agency Packer Forbes Communications is strengthening its leadership team by appointing Joella Webber as managing director. Webber who was …

Appointment
Alimta image

NICE rejects Alimta

February 28, 2014
Sales and Marketing Alimta, Cancer, NHS, NICE, NSCLC, lilly, pemetrexed

Eli Lilly is coming to terms with rejection by NICE after the cost watchdog said it would not recommend Alimta …

News
Novartis image

Novartis extends trial transparency

February 27, 2014
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency

Novartis has become the latest pharmaceutical company to allow greater scrutiny of its clinical trial data.

News

MPs concerned about care.data

February 27, 2014
Medical Communications, Sales and Marketing Dorrell, HSCIC, MPs, NHS, UK, care data, care.data, data

MPs have expressed concerns about security in the delayed NHS care.data programme which will see medical information routinely swapped between …

News
novartis image

Novartis to axe Horsham site

February 27, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Horsham, Novartis, closure, cuts, research, restructure

Novartis has confirmed that it will cease all of its pharmaceutical operations at its Horsham, West Sussex site this year. …

News

Biotech industry failed by UK, says UCB

February 27, 2014
Research and Development, Sales and Marketing Cimzia, NHS, UCB, biotech, doliveux, tellier, vimpat

The UK biotechnology industry has ‘missed the boat’ and not fulfilled its potential, according to outgoing UCB chief executive Roch …

News
dave_henderson_ipa_judge

Best of Health Awards judges appointed

February 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Best of Health, IPA, henderson

The 2014 IPA Best of Health Awards which highlight the top creative advertising agencies in the industry has named the …

Appointment
Mid staffs image

Mid Staffs to be ‘dissolved’

February 27, 2014
Sales and Marketing Hunt, Mid Staffs, NHS, NHS England, tsas

The scandal-hit Mid Staffordshire NHS Foundation Trust is to be dissolved, after health secretary Jeremy Hunt accepted the recommendation of …

News
Esbriet image

InterMune scores in lung trial

February 26, 2014
Research and Development, Sales and Marketing Esbriet, FDA, IPF, InterMune, fvc, lung

InterMune has taken another step on its lengthy road to get the US regulator to approve its drug Esbriet for …

News
BMS image

BMS/AZ fat disorder drug gains FDA approval

February 26, 2014
Research and Development, Sales and Marketing AstraZeneca, BMS, FDA, hep C, metreleptin, myalept

Bristol-Myers Squibb and partner AstraZeneca have been granted FDA approval for a new drug to treat rare and potentially fatal …

News
rupert_gowrley

Bupa hires MHP Health head

February 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BUPA, gowrley, mhp health

Rupert Gowrley is leaving his role as joint head at MHP Health in order to start with Bupa as its …

Appointment
lilly image

Lilly’s diabetes drug matches Victoza

February 26, 2014
Research and Development, Sales and Marketing EMA, FDA, Victoza, dulaglutide, lilly

Eli Lilly’s once-weekly diabetes candidate dulaglutide has matched Novo Nordisk’s established once-daily Victoza (liraglutide) when it comes to lowering blood …

News

FDA: India needs more inspectors

February 25, 2014
Manufacturing and Production FDA, India, generics, hamburg

The Food and Drug Administration is to put more inspectors on the ground in India, following a visit there by …

News

Samsung focussing increasingly on health tech

February 25, 2014
Medical Communications, Sales and Marketing Apple, Samsung, digital, health tech, innovation lab, smartwatch

Samsung has partnered with a US university to create a digital health innovation laboratory whilst also unveiling some new health-tracking …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026